Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06347809
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-04-19
First Post:
2024-03-15
Brief Title:
DNA Methylation in Adenocarcinoma of the Prostate Analysis of Validated Biomarkers in Urine
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
DNA Methylation in Adenocarcinoma of the Prostate Analysis of Validated Biomarkers in Urine
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study explores the potential use of DNA markers in the detection of prostate cancer and patient perceptions of this screening approach and other current or future prostate cancer screening and diagnostic tests
Detailed Description:
PRIMARY OBJECTIVE
I To assess the accuracy of MDM candidates individually and in combination assayed from urine and prostatic fluid collected following digital prostate massage for detection of CAP
OUTLINE This is an observational study
PHASE I Participants undergo urine sample collection on study
PHASE II Participants undergo standard prostate massage and collection of prostatic fluid and urine samples on study
All participants complete a questionnaire and have their medical records reviewed on study
I To assess the accuracy of MDM candidates individually and in combination assayed from urine and prostatic fluid collected following digital prostate massage for detection of CAP
OUTLINE This is an observational study
PHASE I Participants undergo urine sample collection on study
PHASE II Participants undergo standard prostate massage and collection of prostatic fluid and urine samples on study
All participants complete a questionnaire and have their medical records reviewed on study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2024-01225 | REGISTRY | None | None |
| 18-006343 | OTHER | Mayo Clinic Institutional Review Board | None |